Agreed. I would like to capitalize on any averaging down opportunities that may come before the inevitable announcements make it clear to the broader investment community that PNV is a significant opportunity with growing income and self-proliferating customer base.
- Forums
- ASX - By Stock
- PNV
- PNV - Chart
PNV - Chart, page-18708
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.06 |
Change
0.010(0.49%) |
Mkt cap ! $1.422B |
Open | High | Low | Value | Volume |
$2.07 | $2.08 | $2.02 | $1.464M | 714.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4237 | $2.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.07 | 15041 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4237 | 2.060 |
1 | 6116 | 2.050 |
2 | 11116 | 2.040 |
2 | 30240 | 2.030 |
4 | 8429 | 2.020 |
Price($) | Vol. | No. |
---|---|---|
2.070 | 15041 | 1 |
2.080 | 21170 | 4 |
2.090 | 76116 | 2 |
2.100 | 17093 | 3 |
2.110 | 33311 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online